Andere talen Protalix BioTherapeutics, Inc.

Aandelen

PLX

US74365A3095

Geschatte realtime Cboe BZX Andere beurzen 20:26:26 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,165 ^USD	-2,92%		-2,50%	-34,27%

14/03	Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024
14/03	Protalix BioTherapeutics, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	15/03
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	08/03
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	26/02
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	07/11
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Protalix: Q3 Earnings Snapshot	06/11
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	06/11
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	31-10-23
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23-10-23
Protalix BioTherapeutics Issues Statement Regarding Security Situation in Israel	10-10-23
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors	13-09-23
Protalix Biotherapeutics Appoints Eliot Richard Forster to Succeed Zeev Bronfeld as Chairman, Effective as of September 14, 2023	12-09-23
Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference	07-09-23
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results	08-08-23
Protalix BioTherapeutics : PLX Corporate Presentation (August 2023)	07-08-23
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q2 Revenue $35.1M	07-08-23
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07-08-23
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference	02-08-23
Protalix BioTherapeutics to Announce Second Quarter 2023 Financial and Business Results on August 7, 2023	01-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Protalix BioTherapeutics, Inc.

Aandelen

PLX

US74365A3095

Andere talen

Filters